Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Brain Communications|September 21, 2020
A toxic subset of soluble α-synuclein species in dementia with Lewy bodyDiana L Castillo-CarranzaCurrent Opinion in Gastroenterology|October 9, 2013
Novel anticoagulants: bleeding risk and management strategiesNeena S Abraham, Diana L CastilloClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2008
Knowledge management: how to keep up with the literatureDiana L Castillo, Neena S AbrahamACS Chemical Neuroscience|July 31, 2014
Advances in therapeutics for neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau speciesJulia E Gerson, Diana L Castillo-Carranza, Rakez KayedFrontiers in Bioscience (Scholar Edition)|January 2, 2013
Tau aggregates as immunotherapeutic targetsDiana L Castillo-Carranza, Cristian A Lasagna-Reeves, Rakez KayedFrontiers in Cellular Neuroscience|December 24, 2015
Tau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseaseMarcos J Guerrero-Muñoz, Julia Gerson, Diana L Castillo-CarranzaImmunotargets and Therapy|July 30, 2016
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?Diana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Rakez KayedBiochemical Pharmacology|January 11, 2014
Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteinsMarcos J Guerrero-Muñoz, Diana L Castillo-Carranza, Rakez KayedFrontiers in Aging Neuroscience|September 5, 2022
The prion-like transmission of tau oligomers <i>via</i> exosomesNoel A Jackson, Marcos J Guerrero-Muñoz, Diana L Castillo-CarranzaFrontiers in Aging Neuroscience|April 20, 2017
Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial DamageScott S Shafiei, Marcos J Guerrero-Muñoz, Diana L Castillo-CarranzaPageof 4